{"transactions":[{"id":718233,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T22:28:41.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":15528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Plan) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":15528,"derivative":{"exercise_price":28.14,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":15528},"source":{"system":"sec-edgar","filing":"0001326228-26-000004","document":"form4-07022026_100738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000132622826000004/form4-07022026_100738.xml","form_type":"4"}},{"id":718232,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T22:28:41.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":3553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant.  The shares underlying this RSU vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the \"Plan\")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":27082,"source":{"system":"sec-edgar","filing":"0001326228-26-000004","document":"form4-07022026_100738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000132622826000004/form4-07022026_100738.xml","form_type":"4"}},{"id":919260,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-05T01:40:04.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on February 2, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":550000,"derivative":{"exercise_price":22.67,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001104659-26-010472","document":"tm265104-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000110465926010472/tm265104-4_4seq1.xml","form_type":"4"}},{"id":1077669,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-01T20:05:11.000Z","date":"2025-07-30","kind":"grant","planned":false,"acquired":true,"shares":49800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the \"Plan\")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":49800,"derivative":{"exercise_price":4.1,"expiration_date":"2035-07-29","underlying":"Common Stock","underlying_shares":49800},"source":{"system":"sec-edgar","filing":"0001415889-25-020836","document":"form4-08012025_040807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588925020836/form4-08012025_040807.xml","form_type":"4"}},{"id":1267011,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T21:27:36.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on February 3, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":380000,"derivative":{"exercise_price":27.56,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":380000},"source":{"system":"sec-edgar","filing":"0001104659-25-014175","document":"tm256714-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000110465925014175/tm256714-5_4seq1.xml","form_type":"4"}},{"id":1465993,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T20:42:47.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":4278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in 36 equal monthly installments from January 27, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":4278,"derivative":{"exercise_price":8.84,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":4278},"source":{"system":"sec-edgar","filing":"0001415889-24-018608","document":"form4-07012024_080744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018608/form4-07012024_080744.xml","form_type":"4"}},{"id":1465992,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T20:42:47.000Z","date":"2024-07-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in 36 equal monthly installments from January 27, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":8.84,"expiration_date":"2032-01-26","underlying":"Class A Common Stock","underlying_shares":4278},"source":{"system":"sec-edgar","filing":"0001415889-24-018608","document":"form4-07012024_080744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018608/form4-07012024_080744.xml","form_type":"4"}},{"id":1465991,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T20:42:47.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":31016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests over a 3-year period, with 1/3 of the total number of shares subject to the option vesting on each of the first three anniversaries of June 21, 2024, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":31016,"derivative":{"exercise_price":16,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":31016},"source":{"system":"sec-edgar","filing":"0001415889-24-018608","document":"form4-07012024_080744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018608/form4-07012024_080744.xml","form_type":"4"}},{"id":1465990,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T20:42:47.000Z","date":"2024-07-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in 36 equal monthly installments from January 27, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2034-06-26","underlying":"Class A Common Stock","underlying_shares":31106},"source":{"system":"sec-edgar","filing":"0001415889-24-018608","document":"form4-07012024_080744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018608/form4-07012024_080744.xml","form_type":"4"}},{"id":1465989,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T20:42:47.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":31016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests over a 3-year period, with 1/3 of the total number of shares subject to the option vesting on each of the first three anniversaries of June 21, 2024, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":31016,"derivative":{"exercise_price":16,"expiration_date":"2034-06-26","underlying":"Class A Common Stock","underlying_shares":31016},"source":{"system":"sec-edgar","filing":"0001415889-24-018608","document":"form4-07012024_080744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018608/form4-07012024_080744.xml","form_type":"4"}},{"id":1465988,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T20:42:47.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":23529,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."}],"balance_after":23529,"source":{"system":"sec-edgar","filing":"0001415889-24-018608","document":"form4-07012024_080744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018608/form4-07012024_080744.xml","form_type":"4"}},{"id":1465987,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-01T20:42:47.000Z","date":"2024-07-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23529,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-018608","document":"form4-07012024_080744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018608/form4-07012024_080744.xml","form_type":"4"}},{"id":1832830,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-07T20:20:08.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":44983,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44983,"derivative":{"exercise_price":0.29,"exercise_date":"2024-07-05","expiration_date":"2033-07-04","underlying":"Common Stock","underlying_shares":44983},"source":{"system":"sec-edgar","filing":"0000950170-23-032252","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000095017023032252/ownership.xml","form_type":"4"}},{"id":1923621,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:37:56.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":23122,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested."}],"balance_after":23122,"derivative":{"exercise_price":1.64,"expiration_date":"2018-03-18","underlying":"Common Stock","underlying_shares":23122},"source":{"system":"sec-edgar","filing":"0001209191-23-023684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919123023684/doc4.xml","form_type":"4"}},{"id":1923620,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:37:56.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23122,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested."}],"balance_after":0,"derivative":{"exercise_price":4.31,"expiration_date":"2018-03-18","underlying":"Common Stock","underlying_shares":23122},"source":{"system":"sec-edgar","filing":"0001209191-23-023684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919123023684/doc4.xml","form_type":"4"}},{"id":1923619,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:37:56.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":9556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."}],"balance_after":9556,"derivative":{"exercise_price":1.64,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":9556},"source":{"system":"sec-edgar","filing":"0001209191-23-023684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919123023684/doc4.xml","form_type":"4"}},{"id":1923618,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:37:56.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":9556},"source":{"system":"sec-edgar","filing":"0001209191-23-023684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919123023684/doc4.xml","form_type":"4"}},{"id":1923617,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:37:56.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":61678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Yao's continued service on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Yao's continued service on such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Yao's continued service on such vesting date."}],"balance_after":61678,"derivative":{"exercise_price":1.64,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":61678},"source":{"system":"sec-edgar","filing":"0001209191-23-023684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919123023684/doc4.xml","form_type":"4"}},{"id":1923616,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:37:56.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":61678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Yao's continued service on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Yao's continued service on such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Yao's continued service on such vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.82,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":61678},"source":{"system":"sec-edgar","filing":"0001209191-23-023684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919123023684/doc4.xml","form_type":"4"}},{"id":2231328,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T20:57:03.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":61678,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61678,"derivative":{"exercise_price":1.82,"exercise_date":"2023-06-13","expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":61678},"source":{"system":"sec-edgar","filing":"0001209191-22-037006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919122037006/doc4.xml","form_type":"4"}},{"id":2789043,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-15T13:15:11.000Z","date":"2021-03-15","kind":"disposition_to_issuer","acquired":false,"shares":309375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2028-05-10","underlying":"Common Stock","underlying_shares":309375},"source":{"system":"sec-edgar","filing":"0000899243-21-011495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000089924321011495/doc4.xml","form_type":"4"}},{"id":2789042,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-15T13:15:11.000Z","date":"2021-03-15","kind":"disposition_to_issuer","acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."}],"balance_after":0,"derivative":{"exercise_price":15.84,"expiration_date":"2029-08-25","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-21-011495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000089924321011495/doc4.xml","form_type":"4"}},{"id":2789041,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-15T13:15:11.000Z","date":"2021-03-15","kind":"disposition_to_issuer","acquired":false,"shares":188057,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding options that was otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was accelerated and became fully vested, and each of such outstanding options was canceled and converted into the right to receive a cash amount (without interest) equal to the product of (i) the number of shares subject to such option, multiplied by (ii) the excess of (x) $53.00 over (y) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the unvested and outstanding options that was not otherwise eligible to vest in accordance with its terms on or before June 1, 2021, subject solely to the continued services of the holder of such option with the Issuer through such date, was converted into into an option to purchase Ultimate Parent ordinary shares, subject to substantially the same vesting terms and conditions as were applicable to such option immediately prior to the Effective Time, with respect to the number of Ultimate Parent ordinary shares determined by multiplying (i) the number of shares subject to such option immediately prior to the Effective Time and (ii) an exchange ratio equal to 0.6047."}],"balance_after":0,"derivative":{"exercise_price":41.1,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":188057},"source":{"system":"sec-edgar","filing":"0000899243-21-011495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000089924321011495/doc4.xml","form_type":"4"}},{"id":2789040,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-15T13:15:11.000Z","date":"2021-03-13","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":53,"value":10600000.0,"ownership":{"direct":false,"nature":"Held by Yao Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated January 31, 2021 (the \"Merger Agreement\"), by and among the Issuer, Horizon Therapeutics USA, Inc., Teiripic Merger Sub, Inc. (\"Purchaser\"), and for certain purposes, Horizon Therapeutics plc (\"Ultimate Parent\"), including the completion on March 13, 2021 of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $53.00 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Purchaser on on March 15, 2021. Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-011495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000089924321011495/doc4.xml","form_type":"4"}},{"id":2789039,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-15T13:15:11.000Z","date":"2021-03-13","kind":"disposition_to_issuer","acquired":false,"shares":270219,"price":53,"value":14321607.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated January 31, 2021 (the \"Merger Agreement\"), by and among the Issuer, Horizon Therapeutics USA, Inc., Teiripic Merger Sub, Inc. (\"Purchaser\"), and for certain purposes, Horizon Therapeutics plc (\"Ultimate Parent\"), including the completion on March 13, 2021 of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $53.00 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Purchaser on on March 15, 2021. Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-011495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000089924321011495/doc4.xml","form_type":"4"}},{"id":2858773,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-16T19:56:22.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":9556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable at the first anniversary of the vesting commencement date (2/11/21)."}],"balance_after":32678,"derivative":{"exercise_price":17,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":9556},"source":{"system":"sec-edgar","filing":"0001209191-21-010676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919121010676/doc4.xml","form_type":"4"}},{"id":3227092,"issuer":{"id":141253,"kind":"organization","name":"Viela Bio, Inc.","symbol":"VIE"},"owners":[{"id":32935,"kind":"person","name":"Yao Zhengbin","position":1,"cik":"0001326228","reported_name":"Yao Zhengbin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-04T21:43:57.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":188057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on March 2, 2021 with the remainder vesting in equal installments every three months thereafter ending on March 2, 2024."}],"balance_after":188057,"derivative":{"exercise_price":41.1,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":188057},"source":{"system":"sec-edgar","filing":"0001209191-20-016143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326228/000120919120016143/doc4.xml","form_type":"4"}}]}